Article
Cyanoquinolines with independent corrector and potentiator activities restore ΔPhe508-cystic fibrosis transmembrane conductance regulator chloride channel function in cystic fibrosis.
Molecular pharmacology - 1 Oct 2011
Phuan Puay-Wah, Yang Baoxue, Knapp John M, Wood Alex B, Lukacs Gergely L, Kurth Mark J, Verkman A S
Abstract excerpt
The ΔPhe508 mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) protein impairs its folding, stability, and chloride channel gating. Although small molecules that separately correct defective ΔPhe508-CFTR folding/cellular processing ("correctors") or chloride channel gating ("potentiators") have been discovered and are in clinical trials, single compounds with bona fide dual corrector and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
